Reviva to Present Anti-Inflammatory Impacts of Brilaroxazine in Schizophrenia from the RECOVER 12-month Open Label Extension Trial at Neuroscience 2025 GlobeNewswire November 12, 2025 CUPERTINO, Calif., Nov. 12, 2025 (GLOBE NEWSWIRE) — Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a late-stage pharmaceutical company developing therapies that seek to address unmet medical needs […]

Kalaris Reports Third Quarter 2025 Financial Results and Provides Business Updates GlobeNewswire November 12, 2025 Phase 1a Single Ascending Dose trial remains on track for initial clinical data to be reportedby year end 2025 Phase 1b/2 Multiple Ascending Dose trial currently enrolling, intended to inform dose selection for potential Phase 3 development program; initial clinical

Advancing Zonal Architecture with 10BASE-T1S Endpoints for Smarter Remote Connectivity Microchip's LAN866x 10BASE-T1S endpoint devices help eliminate the need to write software for network nodes GlobeNewswire November 12, 2025 CHANDLER, Ariz., Nov. 12, 2025 (GLOBE NEWSWIRE) — As the automotive industry transitions to zonal architectures for in-vehicle networking, designers face increasing challenges in connecting a

LTU and MedCerts Partner to Power the Next Generation of Healthcare and IT Professionals New collaboration expands access to more than 50 online healthcare and technology certification programs, creating flexible, future-focused pathways for students and working professionals. GlobeNewswire November 12, 2025 SOUTHFIELD, Mich., Nov. 12, 2025 (GLOBE NEWSWIRE) — As technology reshapes every industry, Lawrence

LB Pharmaceuticals Appoints Kaya Pai Panandiker as Chief Commercial Officer GlobeNewswire November 12, 2025 NEW YORK, Nov. 12, 2025 (GLOBE NEWSWIRE) — LB Pharmaceuticals, Inc (“LB Pharmaceuticals” or the “Company”) (Nasdaq: LBRX), a clinical-stage biopharmaceutical company developing novel therapies for schizophrenia, bipolar depression, and other neuropsychiatric diseases, today announced the appointment of Kaya Pai Panandiker

65% of Developers Expect Their Roles To Be Redefined by AI in 2026 The Dev Barometer by BairesDev also found that 4 in 10 developers expanded career opportunities in 2025 thanks to AI, 7 out of 10 improved technical skills, and half reported better work-life balance GlobeNewswire November 12, 2025 MOUNTAIN VIEW, Calif., Nov. 12,

Kratos' $50 Million State-of-the-Art Hypersonic System Indiana Payload Integration Facility on Track for 2026 GlobeNewswire November 12, 2025 SAN DIEGO, Nov. 12, 2025 (GLOBE NEWSWIRE) — Kratos Defense & Security Solutions, Inc. (Nasdaq: KTOS), a technology company in the defense, national security, and global markets, today announced that its Indiana Payload Integration Facility (IPIF) for

Bitcoin Depot Expands into Hong Kong, Marking First Asia Expansion Launch in Key Global Crypto Market Signals Company's Growing International Momentum GlobeNewswire November 12, 2025 ATLANTA, Nov. 12, 2025 (GLOBE NEWSWIRE) — Bitcoin Depot (NASDAQ: BTM), a U.S.-based Bitcoin ATM (“BTM”) operator and leading fintech company, today announced its entrance into the Asian market with

Byrna Technologies Named in Forbes' America's Most Successful Small-Cap Companies List GlobeNewswire November 12, 2025 ANDOVER, Mass., Nov. 12, 2025 (GLOBE NEWSWIRE) — Byrna Technologies Inc. (“Byrna” or the “Company”) (Nasdaq: BYRN), a personal defense technology company specializing in the development, manufacture, and sale of innovative less-lethal personal security solutions, today announced that it has

Marotta Controls Secures Contract with L3Harris for Thrust Vector Control System Development Win expands Marotta's product portfolio into new market sector GlobeNewswire November 12, 2025 MONTVILLE, N.J., Nov. 12, 2025 (GLOBE NEWSWIRE) — Marotta Controls, a rapidly growing aerospace and defense supplier, today announced that it has been awarded a contract by L3Harris Technologies (NYSE: